SUBSCRIBE
SUBSCRIBE

MAIA Biotechnology

IN THE PRESS
Press Releases
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer
July 28, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy
July 18, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer
July 9, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress
July 1, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board
June 24, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies
June 18, 2025
 · 
4 min read
Press Releases
MAIA Biotechnology to Present at BIO International Convention 2025
June 10, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial
June 5, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer
June 5, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Announces Private Placement of Approximately $669,500
May 28, 2025
 · 
4 min read
Load More
JOBS